Search for: "Low v. Robb" Results 1 - 12 of 12
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
8 Oct 2015, 9:14 pm by Mark Summerfield
  In particular, all seven High Court judges found that claims 1-3 of Myriad Genetics’ Australian patent no. 686004, each of which is directed to isolated nucleic acid molecules corresponding with the BRCA mutation associated with increased breast cancer risk, are invalid because they do not define a patent-eligible ‘manner of manufacture’ under Australian law: D'Arcy v Myriad Genetics Inc [2015] HCA 35.In arriving at this ruling, the High Court has reversed the… [read post]
12 Dec 2007, 6:53 pm
In light of the Supreme Court decision this week in Kimbrough v. [read post]
25 Jan 2011, 4:30 am by Jim Dedman
Purcell, all of the Rodey, Dickason, Sloan, Akin, & Robb, P.A. firm in Albuquerque, New Mexico. [read post]